Health & MedicinePartially True
mRNA vaccine myocarditis disclosure timing (2021-23)
A myocarditis safety signal following mRNA COVID-19 vaccines was detected by Israeli health authorities in April 2021. The CDC ACIP confirmed elevated risk in young males at its June 2021 meeting, and FDA + manufacturer labels were updated by July 2021. Peer-reviewed studies (Patone et al Nature Medicine 2022; Le Vu et al Nature Communications 2022) confirmed the signal. Israeli Ministry of Health internal documents released via FOI in 2022 showed earlier internal awareness than public statements. The myocarditis risk in young males (approximately 1-10 per 100,000 doses) and its generally favourable recovery profile are not disputed. Whether the disclosure timeline constitutes 'concealment' or 'appropriate regulatory process' is the contested framing question.
15 sources4% confidencefully sourced